Adenosinergic Protection of Dopaminergic and GABAergic Neurons against Mitochondrial Inhibition through Receptors Located in the Substantia Nigra and Striatum, Respectively

Journal of Neuroscience

Volumn 23, Issue 34, 2003, Pages 10982-10987

  Alfinito, Peter D ^a   Wang, Sheng Ping ^a   Manzino, Lawrence ^a   Rijhsinghani, Sonia ^a   Zeevalk, Gail D ^a   Sonsalla, Patricia K ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

A1 antagonist; A2a antagonist; Adenosine receptors; Huntington's disease; Malonate; Neuroprotection; Parkinson's disease

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 4 AMINOBUTYRIC ACID; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; DOPAMINE; MALONIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GABAERGIC TRANSMISSION; HUNTINGTON CHOREA; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR BLOCKING; SUBSTANTIA NIGRA;

EID: 0345060347     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-34-10982.2003     Document Type: Article

References (33)

1. Albers DS, Zeevalk GD, Sonsalla PK (1996) Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP. Brain Res 718:217-220.
2. Alexander SP, Reddington M (1989) The cellular localization of adenosine receptors in rat neostriatum. Neuroscience 3:645-651.
3. Beal MF, Brouillet E, Jenkins B, Henshaw R, Rosen B, Hyman BT (1993) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 61:1147-1150.
4. 2a antagonists. J Neurosci 23:5361-5369.
5. 2a adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 21:RC143(1-6).
6. Corsi C, Pazzagli M, Bianchi L, Della Corte D, Pepeu G, Pedata F (1997) In vivo amino acid release from the striatum of aging rats: adenosine modulation. Neurobiol Aging 18:243-250.
7. de Mendonca A, Sebastião AM, Ribeiro JA (2000) Adenosine: does it have a neuroprotective role after all? Brain Res Brain Res Rev 33:258-274.
8. 1-receptors in human brain: characterization and autoradiographic visualization. Neurosci Lett 65:127-132.
9. Figueredo-Cardenas G, Chen Q, Reiner A (1997) Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats. Exp Neurol 146:444-457.
10. 1 receptor-mediated depression of corticostriatal and thalamostriatal synaptic potentials in vitro. Brain Res 778:178-185.
11. 2a receptor antagonist in MPTP-treated monkeys. Neurology 52:1673-1677.
12. Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AHV (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39:385-389.
13. Hassel B, Bråthe A, Petersen D (2002) Cerebral dicarboxylate transport and metabolism studied with isotopically labeled fumarate, malate and malonate. J Neurochem 82:410-419.
14. 2a receptor blockade in experimental models of Parkinson's disease. J Neurochem 80:262-270.
15. 2 agonist, CGS 21680. Pharmacol Biochem Behav 45:913-919.
16. Jin ZL, Lee TF, Zhou SJ, Wang LCH (1993) Age-dependent change in the inhibitory effect of an adenosine agonist on hippocampal acetylcholine release in rats. Brain Res Bull 30:149-152.
17. 3H]CGS 21680 to rat brain using autoradiography. Neuropharmacology 34:393-403.
18. 1 adenosine receptor function in genetic obesity. FASEB J 8:72-80.
19. Maragos WF, Silverstein FS (1995) The mitochondrial inhibitor malonate enhances NMDA toxicity in the neonatal rat striatum. Brain Res Dev Brain Res 88:117-121.
20. Messam CA, Greene JG, Greenamyre JT, Robinson MB (1995) Intrastriatal injections of succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids that is blocked by MK-801. Brain Res 684:221-224.
21. Moy LY, Zeevalk GD, Sonsalla PK (2000) Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures. J Neurochem 74:1656-1665.
22. Nakao N, Nakai E, Nakai K, Itakura T (1999) Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid. Ann Neurol 45:640-651.
23. Parker Jr WD, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26:719-723.
24. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, Ed 2. New York: Academic.
25. 2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res 705:79-84.
26. 2a receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases in the striatum. J Neurosci 22:1967-1975.
27. 2 receptor antagonist prevents frontal cortex EEG abnormalities in a rat model of Huntington's disease. Brain Res 831:315-318.
28. Reinhard Jr JF, O'Callaghan JP (1991) Measurement of tyrosine hydroxylase apoenzyme protein by enzyme-linked immunosorbent assay (ELISA): effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity and content. Anal Biochem 196:296-301.
29. 1 receptor regulate synaptic transmission to rat substantia nigra reticulate neurons. J Physiol (Lond) 505:153-163.
30. Slotnick BM, Leonard CM (1975) A stereotaxic atlas of the albino mouse forebrain. Washington, DC: United States Government Printing Office.
31. Sonsalla PK, Youngster SK, Kindt MV, Heikkila RE (1987) Characteristics of 1-methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse. J Pharmacol Exp Ther 242:850-857.
32. Zeevalk GD, Manzino L, Hoppe J, Sonsalla P (1997) In vivo vulnerability of dopamine neurons to inhibition of energy metabolism. Eur J Pharmacol 320:111-119.
33. Zeevalk GD, Manzino L, Sonsalla PK (2000) NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum. Exp Neurol 161:638-646.